Target & Activity
| Target | Activity | Value |
|---|---|---|
| KDM4 |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| Breast carcinoma cell | IC50 | 5 nM | Cytotoxicity against HER2-positive patient-derived breast cancer organoid model BR0869f after 5 days by Celltiter-Glo luminescent cell viability assay | [PMID: 28835804] |
| Colon carcinoma cell | IC50 | 13 nM | Cytotoxicity against patient-derived colon cancer organoid model SU60 after 96 to 168 hrs by Celltiter-Glo luminescent cell viability assay | [PMID: 28835804] |
| KYSE-150 cell line | EC50 | 3.5 nM | Antiproliferative activity against human KYSE-150 cells after 168 hrs by 5-bromo-2'-deoxyuridine thymidine incorporation assay | [PMID: 35838529] |
| KYSE-150 cell line | EC50 | 3.5 nM | Antiproliferative activity against human KYSE-150 cells after 168 hrs by 5-bromo-2'-deoxyuridine thymidine incorporation assay | [PMID: 28835804] |